Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Februar 2023

Genmab — Februar 2023

Planlagt Fastgjort Låst Flyttet Genmab
713 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • D Offline
    D Offline
    deleted-user
    wrote on sidst redigeret af
    #695

    Jan lægger på +40 mio. i 2022 og med en tabt voldgift i baggagen i årets l
    , så syns jeg det er voldsomt.

    1 Reply Last reply
    0
    • E Offline
      E Offline
      E_L
      wrote on sidst redigeret af
      #696

      ADC Therapeutics Reports Fourth Quarter and Full Year 2022 - Cami (camidanlumab tesirine)

      Based on the positive pivotal Phase 2 data, the Company is actively seeking a partner to progress this program.

      1 Reply Last reply
      0
      • D Offline
        D Offline
        deleted-user
        wrote on sidst redigeret af
        #697

        Voldsomt er måske "voldsomt" at bruge .... men det er hvert fald en flot løn, taget årets begivenheder in mente. Nuvel væksten er god, men voldgiften har potentialet kostet 12-13 % af +100-120 mia. kr. Mindes ikke Novo nogensinde har leveret samme streg i regningen

        1 Reply Last reply
        0
        • D Offline
          D Offline
          deleted-user
          wrote on sidst redigeret af
          #698

          Så tror jeg, at jeg har udtrykt mig til strækkeligt om lønninger og det forhold, at øget (US) lønniveau ikke er en nødvendig forudsætning for, at tiltrække dygtige medarbejdere og skabe store succes. Slut herfra, for i dag 🙂

          1 Reply Last reply
          0
          • StockBullS Offline
            StockBullS Offline
            StockBull
            wrote on sidst redigeret af
            #699

            Ja ok der mener jeg så en CEO skal måles på de resultater der kommer i hus og ikke den som fejler af den ene eller anden grund. Kurs stigning på +18% i snit sinde 2015 er ok og slutter i over 3400kr i år er det 8 år i træk. Over and out

            1 Reply Last reply
            0
            • SolsenS Offline
              SolsenS Offline
              Solsen
              wrote on sidst redigeret af
              #700

              Den tabte voldgift må JW tage sin del af æren for. Lad os få afgørelsen og se om vi er fortabte. Det burde få ham til at være lidt ydmyg, hvis den nuværende voldgift tabes.

              1 Reply Last reply
              0
              • E Offline
                E Offline
                E_L
                wrote on sidst redigeret af
                #701

                3rd red month in a row. Since the lows of 2011 we only once had 4 negative months in a row, at the end of 2017

                1 Reply Last reply
                0
                • E Offline
                  E Offline
                  E_L
                  wrote on sidst redigeret af
                  #702

                  2021 started with 3 red months after which we nicely rallied from 1900 to 3100+ ; all green months. That lasted the whole summer though, so maybe we should start vacations early 😉

                  1 Reply Last reply
                  0
                  • P Offline
                    P Offline
                    Pensionisten
                    wrote on sidst redigeret af
                    #703

                    I started 01.01.2023, 🙂

                    1 Reply Last reply
                    0
                    • G Offline
                      G Offline
                      gentogen
                      wrote on sidst redigeret af
                      #704

                      For the first time, we report a successful approach to the treatment of refractory anti-NMDAR encephalitis
                      using the fully human anti-CD20 monoclonal antibody ofatumumab, which serves as an important
                      reference for the treatment of autoimmune encephalitis. In our cases, satisfactory clinical outcomes were still observed in anti-NMDR encephalitis
                      while first-line therapy failed. Thus, the case report provides reference for new treatment options of
                      autoimmune encephalitis

                      1 Reply Last reply
                      0
                      • G Offline
                        G Offline
                        gentogen
                        wrote on sidst redigeret af
                        #705

                        https://assets.researchsquare.com/files/rs-2565559/v1/44257c98-f5d5-4bf9-8fe2-f350845789d7.pdf?c=1676475873

                        1 Reply Last reply
                        0
                        • G Offline
                          G Offline
                          gentogen
                          wrote on sidst redigeret af
                          #706

                          Our Alem-Ofa dual-targeted immunotherapy study showed that it is an early example of a chemotherapy-free treatment option with several advantages even in the modern treatment era. First the treatment is of a limited and short duration of no longer than 4.5 months. Second, it was able to achieve rapid onset, deep and durable response; most patients needed no additional therapy in the next five years.

                          1 Reply Last reply
                          0
                          • G Offline
                            G Offline
                            gentogen
                            wrote on sidst redigeret af
                            #707

                            Link Preview Image
                            ScienceDirect

                            favicon

                            (www.sciencedirect.com)

                            1 Reply Last reply
                            0
                            • G Offline
                              G Offline
                              gentogen
                              wrote on sidst redigeret af
                              #708

                              Alem-Ofa is effective in untreated CLL with ORR 98%, CR 48% and 60% bone marrow uMRD

                              1 Reply Last reply
                              0
                              • E Offline
                                E Offline
                                E_L
                                wrote on sidst redigeret af
                                #709

                                @gentogen this was from December - https://www.frontiersin.org/articles/10.3389/fneur.2020.602102/full - Dara competing with Ofa, wouldn't that be fun

                                1 Reply Last reply
                                0
                                • E Offline
                                  E Offline
                                  E_L
                                  wrote on sidst redigeret af
                                  #710

                                  or better yet, surely they
                                  can be combined 😉

                                  1 Reply Last reply
                                  0
                                  • SolsenS Offline
                                    SolsenS Offline
                                    Solsen
                                    wrote on sidst redigeret af
                                    #711

                                    https://www.linkedin.com/posts/claus-johansen-729292_genmab-newtakeovertarget-tivdak-activity-7036295466224898049-VRdi?utm_source=share&utm_medium=member_ios Takeover target ?

                                    1 Reply Last reply
                                    0
                                    • BulderB Offline
                                      BulderB Offline
                                      Bulder
                                      wrote on sidst redigeret af
                                      #712

                                      Tak gentogen. Hjernebetændelse rammer 250.000 hvert år alene i usa https://www.hopkinsmedicine.org/health/conditions-and-diseases/encephalitis

                                      1 Reply Last reply
                                      0
                                      • BulderB Offline
                                        BulderB Offline
                                        Bulder
                                        wrote on sidst redigeret af
                                        #713

                                        Og hvis ofa kunne få revanche i Cll, står verden da ikke længere.

                                        1 Reply Last reply
                                        0
                                        • SolsenS Offline
                                          SolsenS Offline
                                          Solsen
                                          wrote on sidst redigeret af
                                          #714

                                          Ret spændende gentogen. Med desværre er begge stoffer trukket væk fra cancer området. Nu i RRMS som jeg husker.

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper